Table 2.

Medical characteristics of lung cancer survivor sample (n = 175)

Sample (%)Mean (SD)
Pathologic stage
    IA69.7
    IB30.3
    Missing (n)0
Preoperative FEV1 (% predicted)89.66 (19.37)
    40-598.1
    60-7918.5
    80-9942.8
    100-11924.3
    120-1396.4
    Missing (n)2
Years since treatment completion3.62 (1.23)
    1 to <28.0
    2 to <329.7
    3 to <426.3
    4 to <520.0
    5 to <616.0
    Missing (n)0
Treatment received
    Surgery only91.4
    Surgery + neoadjuvant chemotherapy5.7
    Surgery + adjuvant chemotherapy2.3
    Surgery + adjuvant radiation therapy0.6
    Missing (n)0
Type of surgical resection
    Wedge8.0
    Segmentectomy7.4
    Lobectomy80.0
    Bilobectomy2.3
    Pneumonectomy2.3
    Missing (n)0
Length of hospital stay (d)7.88 (5.35)
    2-533.1
    6-1048.0
    11-1513.7
    ≥165.1
    Missing (n)0
No. surgical complications*0.47 (0.73)
    065.1
    125.1
    27.4
    32.3
    Missing (n)0
Current smoking status
    Current smoker5.8
    Former smoker79.8
    Never smoker14.5
    Missing (n)2
Current weight status25.85 (4.45)
    Normal weight (BMI <25 kg/m2)45.9
    Overweight (BMI 25-29.9 kg/m2)38.2
    Obese (BMI ≥30 kg/m2)15.9
    Missing (n)5
No. current comorbid medical conditions2.47 (1.64)
    010.4
    119.1
    227.2
    316.8
    415.6
    ≥511.0
    Missing (n)2
  • Abbreviations: FEV1 = forced expiratory volume in the first second; BMI = body mass index.

  • * The most common surgical complications were atrial fibrillation (14.9%), prolonged air leak (6.3%), pneumonitis (5.7%), and pneumothorax (4.0%).

  • The most prevalent comorbidities were having a cataract (39.9%), a prior cancer other than lung cancer (32.4%), osteoarthritis (31.8%), chronic obstructive pulmonary disease (24.9%), osteoporosis (20.8%), asthma (20.8%), and heart disease (13.3%).